Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Joanna Drozd-Sokołowska, Anna Waszczuk-Gajda, Przemysław Biecek, Katarzyna Kobylińska, Joanna Mańko, Iwona Hus, Anna Szmigielska-Kapłon, Mateusz Nowicki, Joanna Romejko-Jarosińska, Magdalena Kozioł, Mariola Sędzimirska, Wojciech Sachs, Krzysztof Mądry, Piotr Boguradzki, Małgorzata Król, Marek Hus, Grzegorz Basak & Jadwiga Dwilewicz-Trojaczek. (2021) Salvage autologous hematopoietic stem cell transplantation for multiple myeloma performed with stem cells procured after previous high dose therapy – a multicenter report by the Polish Myeloma Study Group. Leukemia & Lymphoma 62:13, pages 3226-3234.
Read now
Read now
Dipenkumar Modi, Jie Chi, Seongho Kim, Lois Ayash, Asif Alavi, Andrew Kin, Voravit Ratanatharathorn, Joseph P. Uberti & Abhinav Deol. (2020) Lenalidomide maintenance after second autologous stem cell transplant improves overall survival in multiple myeloma. Leukemia & Lymphoma 61:8, pages 1877-1884.
Read now
Read now
Dimitrios C. Ziogas, Evangelos Terpos & Meletios A. Dimopoulos. (2017) When to recommend a second autograft in patients with relapsed myeloma?. Leukemia & Lymphoma 58:4, pages 781-787.
Read now
Read now
Laurent Garderet, Gordon Cook, Holger W. Auner, Benedetto Bruno, Henk Lokhorst, Jose Antonio Perez-Simon, Firoozeh Sahebi, Christof Scheid, Curly Morris, Anja van Biezen, Mohamad Sobh, Mauricette Michallet, Gösta Gahrton, Stefan Schönland & Nicolaus Kröger. (2017) Treatment options for relapse after autograft in multiple myeloma – report from an EBMT educational meeting. Leukemia & Lymphoma 58:4, pages 797-808.
Read now
Read now
Jacob P Laubach, Peter M Voorhees, Hani Hassoun, Andrzej Jakubowiak, Sagar Lonial & Paul G Richardson. (2014) Current strategies for treatment of relapsed/refractory multiple myeloma. Expert Review of Hematology 7:1, pages 97-111.
Read now
Read now
Nicole Wong Doo, Philip A. Thompson, H. Miles Prince, John F. Seymour, David Ritchie, Kerrie Stokes, Kate Burbury, Max Wolf, Trish Joyce & Simon J. Harrison. (2013) Bortezomib with high dose melphalan conditioning for autologous transplant is safe and effective in patients with heavily pretreated and high risk multiple myeloma. Leukemia & Lymphoma 54:7, pages 1465-1472.
Read now
Read now
Morie A. Gertz. (2011) Stem cell transplant: an effective salvage therapy for multiple myeloma. Leukemia & Lymphoma 52:8, pages 1413-1414.
Read now
Read now
Articles from other publishers (41)
Abdullah M. Khan, Michael Ozga, Harshil Bhatt, Muhammad S. Faisal, Sadia Ansari, Qiuhong Zhao, Naresh Bumma, Francesca Cottini, Srinivas Devarakonda, Ashley Rosko, Nidhi Sharma, Elvira Umyarova & Don Benson. (2023) Outcomes After Salvage Autologous Hematopoietic Cell Transplant for Patients With Relapsed/Refractory Multiple Myeloma: A Single-Institution Experience. Clinical Lymphoma Myeloma and Leukemia 23:3, pages e182-e189.
Crossref
Crossref
Joanna Drozd-Sokołowska, Luuk Gras, Nienke Zinger, John A. Snowden, Mutlu Arat, Grzegorz Basak, Anastasia Pouli, Charles Crawley, Keith M. O. Wilson, Herve Tilly, Jennifer Byrne, Claude Eric Bulabois, Jakob Passweg, Zubeyde Nur Ozkurt, Wilfried Schroyens, Bruno Lioure, Mercedes Colorado Araujo, Xavier Poiré, Gwendolyn Van Gorkom, Gunhan Gurman, Liesbeth C. de Wreede, Patrick J. Hayden, Meral Beksac, Stefan O. Schönland & Ibrahim Yakoub-Agha. (2022) Autologous hematopoietic cell transplantation for relapsed multiple myeloma performed with cells procured after previous transplantation–study on behalf of CMWP of the EBMT. Bone Marrow Transplantation 57:4, pages 633-640.
Crossref
Crossref
Henrik Gregersen, Valdas Peceliunas, Kari Remes, Fredrik Schjesvold, Niels Abildgaard, Hareth Nahi, Niels Frost Andersen, Annette Juul Vangsted, Tobias Wirenfeldt Klausen, Carsten Helleberg, Kristina Carlson, Ulf Christian Frølund, Per Axelsson, Olga Stromberg, Cecilie Hveding Blimark, Jacob Crafoord, Galina Tsykunova, Henrik Rode Eshoj, Anders Waage, Markus Hansson & Nina Gulbrandsen. (2021) Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group. European Journal of Haematology 108:1, pages 34-44.
Crossref
Crossref
Oren Pasvolsky, Moshe Yeshurun, Raphael Fraser, Noel Estrada-Merly, Uri Rozovski, Liat Shargian-Alon, Amer Assal, Rahul Banerjee, Naresh Bumma, Robert Peter Gale, Patrick Hagen, Leona Holmberg, Nasheed M. Hossain, Hillard M. Lazarus, Cindy Lee, Hira Mian, Kevin C. Miller, Sunita Nathan, Arnon Nagler, Taiga Nishihori, Ricardo D. Parrondo, Sagar Patel, Mark A. Schroeder, Saad Z. Usmani, Trent Wang, Baldeep Wirk, Shaji Kumar, Nina Shah, Muzaffar H. Qazilbash & Anita D’Souza. (2021) Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis. Bone Marrow Transplantation 57:1, pages 31-37.
Crossref
Crossref
Lakshmi Yarlagadda, Sravani Gundarlapalli, Richa Parikh, Reid D. Landes, Mathew Kottarathara, Yetunde Ogunsesan, Shadiqul Hoque, Angel A. Mitma, Clyde Bailey, Kerri M. Hill, Sharmilan Thanendrarajan, Monica Graziutti, Meera Mohan, Maurizio Zangari, Frits van Rhee, Guido Tricot & Carolina Schinke. (2021) Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma. Cancers 13:16, pages 4019.
Crossref
Crossref
Shaji K. KumarNatalie S. CallanderKehinde AdekolaLarry AndersonMuhamed BaljevicErica CampagnaroJorge J. CastilloJason C. ChandlerCaitlin CostelloYvonne EfeberaMatthew FaimanAlfred GarfallKelly GodbyJens HillengassLeona HolmbergMyo HtutCarol Ann HuffYubin KangMalin HultcrantzSarah LarsonMichaela LiedtkeThomas MartinJames OmelKenneth ShainDouglas SborovKeith Stockerl-GoldsteinDonna Weber, Jennifer Keller & Rashmi Kumar. (2020) Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network 18:12, pages 1685-1717.
Crossref
Crossref
Noa Biran, Scott D. Rowley, David H. Vesole, Shijia Zhang, Michele L. Donato, Alan P. Skarbnik, Joshua Richter, Andrew Pecora & David S. Siegel. (2019) A phase I/II study of escalating doses of thalidomide in conjunction with bortezomib and high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma. Bone Marrow Transplantation 54:11, pages 1881-1891.
Crossref
Crossref
Wilson I. Gonsalves, Francis K. Buadi, Sikander Ailawadhi, P. Leif Bergsagel, Asher A. Chanan Khan, David Dingli, Angela Dispenzieri, Rafael Fonseca, Susan R. Hayman, Prashant Kapoor, Taxiarchis V. Kourelis, Martha Q. Lacy, Jeremy T. Larsen, Eli Muchtar, Craig B. Reeder, Taimur Sher, A. Keith Stewart, Rahma Warsame, Ronald S. Go, Robert A. Kyle, Nelson Leung, Yi Lin, John A. Lust, Stephen J. Russell, Stephen R. Zeldenrust, Amie L. Fonder, Yi L. Hwa, Miriam A. Hobbs, Angela A. Mayo, William J. Hogan, S. Vincent Rajkumar, Shaji K. Kumar, Morie A. Gertz & Vivek Roy. (2018) Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement. Bone Marrow Transplantation 54:3, pages 353-367.
Crossref
Crossref
Patrick Alan Hagen & Patrick Stiff. (2019) The Role of Salvage Second Autologous Hematopoietic Cell Transplantation in Relapsed Multiple Myeloma. Biology of Blood and Marrow Transplantation 25:3, pages e98-e107.
Crossref
Crossref
Mohammed Junaid Hussain & Saad Zafar Usmani. 2019. Hematopoietic Cell Transplantation for Malignant Conditions. Hematopoietic Cell Transplantation for Malignant Conditions
245
253
.
Laurent Garderet, Simona Iacobelli, Linda Koster, Hartmut Goldschmidt, Jan-Erik Johansson, Jean Henri Bourhis, Marta Krejci, Xavier Leleu, Michael Potter, Didier Blaise, Christian Koenecke, Christian Peschel, Jakub Radocha, Bernd Metzner, Pascal Lenain, Kerstin Schäfer-Eckart, David Pohlreich, Mariella Grasso, Denis Caillot, Herman Einsele, Marco Ladetto, Stefan Schönland & Nicolaus Kröger. (2018) Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma. Biology of Blood and Marrow Transplantation 24:7, pages 1372-1378.
Crossref
Crossref
Ursina Gössi, Barbara Jeker, Behrouz Mansouri Taleghani, Ulrike Bacher, Urban Novak, Daniel Betticher, Thomas Egger, Thilo Zander & Thomas Pabst. (2018) Prolonged survival after second autologous transplantation and lenalidomide maintenance for salvage treatment of myeloma patients at first relapse after prior autograft. Hematological Oncology 36:2, pages 436-444.
Crossref
Crossref
Tsuyoshi Muta, Toshihiro Miyamoto, Tomohiko Kamimura, Yoshinobu Kanda, Masaharu Nohgawa, Yasunori Ueda, Koji Iwato, Osamu Sasaki, Takehiko Mori, Naoyuki Uchida, Shinsuke Iida, Takahiro Fukuda, Yoshiko Atsuta & Kazutaka Sunami. (2018) Significance of Salvage Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma: A Nationwide Retrospective Study in Japan. Acta Haematologica 139:1, pages 35-44.
Crossref
Crossref
Beatrice Anna Zannetti, Paola Tacchetti, Lucia Pantani, Barbara Gamberi, Patrizia Tosi, Serena Rocchi, Claudia Cellini, Sonia Ronconi, Annalisa Pezzi, Katia Mancuso, Ilaria Rizzello, Isola Caratozzolo, Marina Martello, Luca Dozza, Michele Cavo & Elena Zamagni. (2017) Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma. Annals of Hematology 96:12, pages 2071-2078.
Crossref
Crossref
D Tremblay, G Lancman, E Moshier, N Bar, S Jagannath & A Chari. (2017) Outcomes of salvage autologous stem cell transplantation for multiple myeloma with cytopenias and exposure to novel agents. Bone Marrow Transplantation 52:10, pages 1468-1470.
Crossref
Crossref
Tsuyoshi Muta, Toshihiro Miyamoto, Tomoaki Fujisaki, Koichi Osaki, Ryosuke Ogawa, Koji Kato, Kenichi Aoki, Takashi Haro, Tomohiko Kamimura, Kenjiro Kamezaki, Goichi Yoshimoto, Satoshi Yamasaki, Katsuto Takenaka, Yuju Ohno, Hiromi Iwasaki, Testuya Eto, Koji Nagafuji, Koichi Akashi & Fukuoka Blood and Marrow Transplant Group (FBMTG). (2017) Significance of salvage autologous stem cell transplantation (ASCT) for patients with multiple myeloma relapsing after up-front ASCT. Journal of Hematopoietic Cell Transplantation 6:2, pages 98-107.
Crossref
Crossref
Marc-Andrea Baertsch, Jana Schlenzka, Elias K. Mai, Maximilian Merz, Jens Hillengaß, Marc S. Raab, Dirk Hose, Patrick Wuchter, Anthony D. Ho, Anna Jauch, Thomas Hielscher, Christina Kunz, Steffen Luntz, Stefan Klein, Ingo G. H. Schmidt-Wolf, Martin Goerner, Martin Schmidt-Hieber, Peter Reimer, Ullrich Graeven, Roland Fenk, Hans Salwender, Christof Scheid, Axel Nogai, Mathias Haenel, Hans W. Lindemann, Hans Martin, Richard Noppeney, Katja Weisel & Hartmut Goldschmidt. (2016) Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma. BMC Cancer 16:1.
Crossref
Crossref
Noa Biran, Scott D. Rowley, David H. Vesole, Shijia Zhang, Michele L. Donato, Joshua Richter, Alan P. Skarbnik, Andrew Pecora & David S. Siegel. (2016) A Phase I/II Study of Escalating Doses of Bortezomib in Conjunction with High-Dose Melphalan as a Conditioning Regimen for Salvage Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple Myeloma. Biology of Blood and Marrow Transplantation 22:12, pages 2165-2171.
Crossref
Crossref
Sergio Giralt, Laurent Garderet, Brian Durie, Gordon Cook, Gosta Gahrton, Benedetto Bruno, Paremesweran Hari, Henk Lokhorst, Phillip McCarthy, Amrita Krishnan, Pieter Sonneveld, Harmut Goldschmidt, Sundar Jagannath, Bart Barlogie, Maria Mateos, Peter Gimsing, Orhan Sezer, Joseph Mikhael, Jin Lu, Meletios Dimopoulos, Amitabha Mazumder, Antonio Palumbo, Rafat Abonour, Kenneth Anderson, Michel Attal, Joan Blade, Jenny Bird, Michele Cavo, Raymond Comenzo, Javier de la Rubia, Hermann Einsele, Ramon Garcia-Sanz, Jens Hillengass, Sarah Holstein, Hans Erik Johnsen, Douglas Joshua, Guenther Koehne, Shaji Kumar, Robert Kyle, Xavier Leleu, Sagar Lonial, Heinz Ludwig, Hareth Nahi, Anil Nooka, Robert Orlowski, Vincent Rajkumar, Anthony Reiman, Paul Richardson, Eloisa Riva, Jesus San Miguel, Ingemar Turreson, Saad Usmani, David Vesole, William Bensinger, Muzaffer Qazilbash, Yvonne Efebera, Mohamed Mohty, Christina Gasparreto, James Gajewski, Charles F. LeMaistre, Chris Bredeson, Phillipe Moreau, Marcelo Pasquini, Nicolaus Kroeger & Edward Stadtmauer. (2015) American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma. Biology of Blood and Marrow Transplantation 21:12, pages 2039-2051.
Crossref
Crossref
Amrita Krishnan & Sergio A. Giralt. 2015. Thomas’ Hematopoietic Cell Transplantation. Thomas’ Hematopoietic Cell Transplantation
625
639
.
Nina Shah, Natalie Callander, Siddhartha Ganguly, Zartash Gul, Mehdi Hamadani, Luciano Costa, Salyka Sengsayadeth, Muneer Abidi, Parameswaran Hari, Mohamad Mohty, Yi-Bin Chen, John Koreth, Heather Landau, Hillard Lazarus, Helen Leather, Navneet Majhail, Rajneesh Nath, Keren Osman, Miguel-Angel Perales, Jeffrey Schriber, Paul Shaughnessy, David Vesole, Ravi Vij, John Wingard, Sergio Giralt & Bipin N. Savani. (2015) Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation 21:7, pages 1155-1166.
Crossref
Crossref
Sarah A. Holstein, Paul G. Richardson, Jacob P. Laubach & Philip L. McCarthy. (2015) Management of Relapsed Multiple Myeloma after Autologous Stem Cell Transplant. Biology of Blood and Marrow Transplantation 21:5, pages 793-798.
Crossref
Crossref
Sarah A. Holstein, Hong Liu & Philip L. McCarthy. (2014) Multiple Myeloma. Hematology/Oncology Clinics of North America 28:6, pages 1113-1129.
Crossref
Crossref
T-F Wang, M A Fiala, A F Cashen, G L Uy, C N Abboud, T Fletcher, N Wu, P Westervelt, J F DiPersio, K E Stockerl-Goldstein & R Vij. (2014) A phase II study of V-BEAM as conditioning regimen before second auto-SCT for multiple myeloma. Bone Marrow Transplantation 49:11, pages 1366-1370.
Crossref
Crossref
Jean-Luc Harousseau & Mohamad Mohty. 2014. Cancer Consult: Expertise for Clinical Practice. Cancer Consult: Expertise for Clinical Practice
376
380
.
C O Freytes, D H Vesole, J LeRademacher, X Zhong, R P Gale, R A Kyle, D E Reece, J Gibson, H C Schouten, P L McCarthy, S Lonial, A Y Krishnan, A Dispenzieri & P N Hari. (2013) Second transplants for multiple myeloma relapsing after a previous autotransplant—reduced-intensity allogeneic vs autologous transplantation. Bone Marrow Transplantation 49:3, pages 416-421.
Crossref
Crossref
Jacopo Olivieri, Luca Pierelli, Martino Introna, Patrizia Accorsi, Alberto Bosi, Paolo Perseghin, Marco Risso, Annino Pandolfi, Stefania Mancini, Monia Marchetti, Simone Dal Pozzo, Elisa Gotti, Alessandro Rambaldi, Pietro Leoni & Attilio Olivieri. (2014) Kinetics of the use of cryopreserved autologous stem cell grafts: a GITMO-SIDEM survey. Cytotherapy 16:1, pages 101-110.
Crossref
Crossref
Djordje Atanackovic & Georgia Schilling. (2013) Second autologous transplant as salvage therapy in multiple myeloma. British Journal of Haematology 163:5, pages 565-572.
Crossref
Crossref
Ivetta Danylesko, Avichai Shimoni & Arnon Nagler. (2013) Allogeneic Stem Cell Transplantation and Targeted Immunotherapy for Multiple Myeloma. Clinical Lymphoma Myeloma and Leukemia 13, pages S330-S348.
Crossref
Crossref
Leopold Sellner, Christiane Heiss, Axel Benner, Marc S. Raab, Jens Hillengass, Dirk Hose, Nicola Lehners, Gerlinde Egerer, Anthony D. Ho, Hartmut Goldschmidt & Kai Neben. (2013) Autologous retransplantation for patients with recurrent multiple myeloma. Cancer 119:13, pages 2438-2446.
Crossref
Crossref
Saad Z. Usmani. (2013) Melphalan Continues to Rock the Myeloma World. Biology of Blood and Marrow Transplantation 19:5, pages 680-681.
Crossref
Crossref
Laura C. Michaelis, Ayman Saad, Xiaobo Zhong, Jennifer Le-Rademacher, Cesar O. Freytes, David I. Marks, Hillard M. Lazarus, Jennifer M. Bird, Leona Holmberg, Rammurti T. Kamble, Shaji Kumar, Michael Lill, Kenneth R. Meehan, Wael Saber, Jeffrey Schriber, Jason Tay, Dan T. Vogl, Baldeep Wirk, Bipin N. Savani, Robert P. Gale, David H. Vesole, Gary J. Schiller, Muneer Abidi, Kenneth C. Anderson, Taiga Nishihori, Matt E. Kalaycio, Julie M. Vose, Jan S. Moreb, William Drobyski, Reinhold Munker, Vivek Roy, Armin Ghobadi, H. Kent Holland, Rajneesh Nath, L. Bik To, Angelo Maiolino, Adetola A. Kassim, Sergio A. Giralt, Heather Landau, Harry C. Schouten, Richard T. Maziarz, Joseph Mikhael, Tamila Kindwall-Keller, Patrick J. Stiff, John Gibson, Sagar Lonial, Amrita Krishnan, Angela Dispenzieri & Parameswaran Hari. (2013) Salvage Second Hematopoietic Cell Transplantation in Myeloma. Biology of Blood and Marrow Transplantation 19:5, pages 760-766.
Crossref
Crossref
W I Gonsalves, M A Gertz, M Q Lacy, A Dispenzieri, S R Hayman, F K Buadi, D Dingli, W J Hogan & S K Kumar. (2012) Second auto-SCT for treatment of relapsed multiple myeloma. Bone Marrow Transplantation 48:4, pages 568-573.
Crossref
Crossref
H-Y Yhim, K Kim, J S Kim, H J Kang, J-A Kim, C-K Min, S H Bae, E Park, D-H Yang, C Suh, M K Kim, Y-C Mun, H S Eom, H J Shin, H-J Yoon, J H Kwon, J H Lee, Y S Kim, S-S Yoon & J-Y Kwak. (2012) Matched-pair analysis to compare the outcomes of a second salvage auto-SCT to systemic chemotherapy alone in patients with multiple myeloma who relapsed after front-line auto-SCT. Bone Marrow Transplantation 48:3, pages 425-432.
Crossref
Crossref
Emilie Lemieux, Cyrille Hulin, Denis Caillot, Stéphanie Tardy, Véronique Dorvaux, Jessica Michel, Thomas Gastinne, Cédric Rossi, Caroline Legouge, Cyrille Touzeau, Lucie Planche, Marion Loirat, Ingrid Lafon & Philippe Moreau. (2013) Autologous Stem Cell Transplantation: An Effective Salvage Therapy in Multiple Myeloma. Biology of Blood and Marrow Transplantation 19:3, pages 445-449.
Crossref
Crossref
A. W. S. Chow, C. H. S. Lee, D. K. Hiwase, L. B. To & N. Horvath. (2013) Relapsed multiple myeloma: who benefits from salvage autografts?. Internal Medicine Journal 43:2, pages 156-161.
Crossref
Crossref
Margarita Blanes & Javier de la Rubia. (2012) Role of autologous bone marrow transplant in multiple myeloma. Current Opinion in Oncology 24:6, pages 733-741.
Crossref
Crossref
Zaid Al-Kadhimi, Zartash Gul, Roberto Rodriguez, Wei Chen, Daryn Smith, Alice Mitchell, Muneer Abidi, Lois Ayash, Abhinav Deol, Lawrence Lum, Stephen Forman, Voravit Ratanatharathorn & Joseph Uberti. (2012) Anti-Thymocyte Globulin (Thymoglobulin), Tacrolimus, and Sirolimus as Acute Graft-versus-Host Disease Prophylaxis for Unrelated Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 18:11, pages 1734-1744.
Crossref
Crossref
Victor H. Jimenez-Zepeda, Joseph Mikhael, Andrew Winter, Norman Franke, Esther Masih-Khan, Suzanne Trudel, Christine Chen, Vishal Kukreti & Donna E. Reece. (2012) Second Autologous Stem Cell Transplantation as Salvage Therapy for Multiple Myeloma: Impact on Progression-Free and Overall Survival. Biology of Blood and Marrow Transplantation 18:5, pages 773-779.
Crossref
Crossref
Naohiro Sekiguchi, Naoki Takezako, Takashi Ishii, Akihisa Nagata, Satoshi Noto & Akiyoshi Miwa. (2012) Successful Treatment of Low-Dose Lenalidomide Maintenance Therapy Followed by Second Autologous Peripheral Blood Stem Cell Transplantation in Heavily Treated Multiple Myeloma. International Journal of Clinical Medicine 03:02, pages 106-109.
Crossref
Crossref
Omar S Aljitawi & Joseph P McGuirk. (2012) Multiple myeloma preparative regimens for high-dose therapy and autologous transplantation: what’s new?. Journal of Comparative Effectiveness Research 1:1, pages 57-70.
Crossref
Crossref